Evidence map›Paper›PMID 26308600›Full record

ReviewExpert review of cardiovascular therapy2015

Understanding the pathogenesis of abdominal aortic aneurysms.

Helena Kuivaniemi, Evan J Ryer, James R Elmore, Gerard Tromp

Abstract readReview
In one paragraph

Review in Expert review of cardiovascular therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 197 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
197citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

197 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. The role of Smoothelin-B in abdominal aortic aneurysm formation.Biochemistry and biophysics reports · 2026
    Article
  20. NFS1 Regulates IDH2 to Attenuate Abdominal Aortic Aneurysms via Interacting With SP2.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article

137 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Helena Kuivaniemia 1 Sigfried and Janet Weis Center for Research, Geisinger Health System, Danville, PA 17822, USA.
Evan J Ryer
James R Elmore
Gerard Tromp

Funding

Geisinger eGenonic Medicine (GeM) ProgramU01HG006382 · NHGRI · GEISINGER CLINIC · PI CAREY, DAVID J., WILLIAMS, MARC S. · 2011 to 2014
$4.3M
GENETIC FACTORS IN ABDOMINAL AORTIC ANEURYSMSR01HL064310 · NHLBI · WAYNE STATE UNIVERSITY · PI KUIVANIEMI, S HELENA · 1999 to 2006
$2.5M
MOLECULAR BIOLOGY OF AORTIC ANEURYSMSR01HL045996 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI KUIVANIEMI, S HELENA · 1991 to 1994
–
NHGRI NIH HHS U01 HG006382NHLBI NIH HHS R01 HL045996NHLBI NIH HHS R01 HL064310
6 · The paper itself

Abstract

An aortic aneurysm is a dilatation in which the aortic diameter is ≥3.0 cm. If left untreated, the aortic wall continues to weaken and becomes unable to withstand the forces of the luminal blood pressure resulting in progressive dilatation and rupture, a catastrophic event associated with a mortality of 50-80%. Smoking and positive family history are important risk factors for the development of abdominal aortic aneurysms (AAA). Several genetic risk factors have also been identified. On the histological level, visible hallmarks of AAA pathogenesis include inflammation, smooth muscle cell apoptosis, extracellular matrix degradation and oxidative stress. We expect that large genetic, genomic, epigenetic, proteomic and metabolomic studies will be undertaken by international consortia to identify additional risk factors and biomarkers, and to enhance our understanding of the pathobiology of AAA. Collaboration between different research groups will be important in overcoming the challenges to develop pharmacological treatments for AAA.

Indexed as

AnimalsAortaAortic Aneurysm, AbdominalDisease Models, AnimalHumansanimal modelsdoxycyclineembryologic originepigeneticsextracellular matrixgenetic susceptibilityinflammationmatrix metalloproteinasesrisk factorssmoking

Identifiers

PMID26308600
PMCPMC4829576

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.